JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 13 February 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.02164-07v1
82/8/4016    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verhoeven, D.
Right arrow Articles by Dandekar, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verhoeven, D.
Right arrow Articles by Dandekar, S.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.02164-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Antiviral Therapy During Primary SIV Infection Fails to Prevent Acute CD4+ T-cell Loss In Gut Mucosa But Enhances Their Rapid Restoration Through Central Memory T-cells

David Verhoeven, Sumathi Sankaran, Melanie Silvey, and Satya Dandekar*

Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, CA

* To whom correspondence should be addressed. Email: sdandekar{at}ucdavis.edu.


   Abstract

Gut associated lymphoid tissue (GALT) is an early target of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) and a site for severe CD4+ T-cell depletion. Although anti-retroviral therapy (ART) is effective in suppressing HIV replication and restoring CD4+ T-cells in peripheral blood, restoration in GALT is delayed. The role of restored CD4+ T-cell help in GALT during ART and its impact on anti-viral CD8+ T-cell responses have not been investigated. Using the SIV model, we investigated gut CD4+ T-cell restoration in infected macaques initiating ART during either the primary (1 week post-infection) stage, prior to acute CD4+ cell loss (PSI), or during chronic stage at 10 weeks post-infection (CSI). ART led to viral suppression in GALT and PBMC of PSI and CSI at comparable levels. CSI animals had incomplete CD4+ T-cell restoration in GALT. In PSI animals, ART did not prevent acute CD4+ T-cell loss by 2 weeks post-infection in GALT but supported rapid and complete CD4+ T-cell restoration thereafter. This correlated with an accumulation of central memory CD4+ T-cells and better suppression of inflammation. Restoration of CD4+ T-cells in GALT correlated with qualitative changes in SIV gag-specific CD8+ T-cell responses with a dominance of IL-2 producing responses in PSI animals, while both CSI macaques and untreated SIV infected controls were dominated by IFN-{gamma} responses. Thus, central memory CD4+ T-cell levels and qualitative anti-viral CD8+ T-cell responses, independent of viral suppression, were the immune correlates of gut mucosal immune restoration during ART.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.